These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 30049442)
21. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149 [TBL] [Abstract][Full Text] [Related]
22. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice. Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194 [TBL] [Abstract][Full Text] [Related]
23. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo. Guo X; Gagne L; Chen H; Szoka FC J Liposome Res; 2014 Jun; 24(2):90-8. PubMed ID: 24188532 [TBL] [Abstract][Full Text] [Related]
24. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon. Li Y; Liu R; Shi Y; Zhang Z; Zhang X Theranostics; 2015; 5(6):583-96. PubMed ID: 25825598 [TBL] [Abstract][Full Text] [Related]
25. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Kim HK; Davaa E; Myung CS; Park JS Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025 [TBL] [Abstract][Full Text] [Related]
26. Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA. Zang X; Ding H; Zhao X; Li X; Du Z; Hu H; Qiao M; Chen D; Deng Y; Zhao X Int J Nanomedicine; 2016; 11():3951-67. PubMed ID: 27574425 [TBL] [Abstract][Full Text] [Related]
27. Anionic amino acid-derived cationic lipid for siRNA delivery. Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256 [TBL] [Abstract][Full Text] [Related]
28. PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G Eur J Pharm Sci; 2016 Oct; 93():493-503. PubMed ID: 27593989 [TBL] [Abstract][Full Text] [Related]
29. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor. Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749 [TBL] [Abstract][Full Text] [Related]
30. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990 [TBL] [Abstract][Full Text] [Related]
31. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy. Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060 [TBL] [Abstract][Full Text] [Related]
32. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages. Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749 [TBL] [Abstract][Full Text] [Related]
33. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery. Naicker K; Ariatti M; Singh M Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720 [TBL] [Abstract][Full Text] [Related]
34. Correlation between structure and transfection efficiency: a study of DC-Chol--DOPE/DNA complexes. Congiu A; Pozzi D; Esposito C; Castellano C; Mossa G Colloids Surf B Biointerfaces; 2004 Jul; 36(1):43-8. PubMed ID: 15261022 [TBL] [Abstract][Full Text] [Related]
35. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes. Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732 [TBL] [Abstract][Full Text] [Related]
36. KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer. Lee J; Cho YJ; Lee JW; Ahn HJ J Control Release; 2020 May; 321():184-197. PubMed ID: 32035195 [TBL] [Abstract][Full Text] [Related]
37. Lipoplex formation using liposomes prepared by ethanol injection. Maitani Y Methods Mol Biol; 2010; 605():393-403. PubMed ID: 20072896 [TBL] [Abstract][Full Text] [Related]
38. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245 [TBL] [Abstract][Full Text] [Related]
39. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S; Miller AD; Keller M Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141 [TBL] [Abstract][Full Text] [Related]
40. PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells. Daniels A; Singh M; Ariatti M Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):206-20. PubMed ID: 24001194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]